Physician

Mahesh M Dangal, M.D.

According to 2025 Medicare claims, Mahesh Dangal, M.D. (NPI: 1710171129) practices nephrology in the Portland-Vancouver-Hillsboro, OR-WA market, with the plurality of this provider's patient population coming from Clark, WA. This provider's primary affiliated billing organization is PEACEHEALTH (NPI: 1609061969; TIN: 910565889) and primary practice location at 98684-3547. Dangal is affiliated with the PeaceHealth Direct Contracting LLC (ACO ID: D0152), participating under the REACH model.

Dangal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 270 traditional Medicare patients, billed 856 HCPCS/CPT codes, and received $131,740 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 1,010 prescription claims across 194 beneficiaries totaling $232,220 in drug costs, led by Velphoro (Sucroferric Oxyhydroxide). DME data shows 150 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $4,836 to $131,740. Similarly, Part D prescription costs have risen steadily, from $502 to $232,220. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	34	65	$4,836
2016	256	764	$60,529
2017	349	987	$89,435
2018	462	1,455	$168,471
2019	509	1,762	$206,513
2020	500	1,622	$207,797
2021	443	1,777	$223,124
2022	384	1,538	$202,104
2023	333	1,303	$175,550
2024	270	856	$131,740

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	18	43	$502
2016	91	522	$39,133
2017	149	819	$81,893
2018	195	1,186	$105,243
2019	165	1,065	$70,530
2020	174	911	$126,058
2021	179	795	$98,679
2022	174	838	$146,135
2023	167	861	$208,232
2024	194	1,010	$232,220

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	122	$5,210
2019	N/R	75	$2,526
2020	N/R	73	$1,446
2021	N/R	133	$3,061
2022	N/R	186	$3,922
2023	N/R	203	$4,009
2024	N/R	150	$2,034

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	61	229	$279
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	46	50	$134
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	56	110	$92
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	115	204	$82
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	51	96	$61

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Velphoro	Sucroferric Oxyhydroxide	45	1,697	$129,937
Auryxia	Ferric Citrate	14	660	$26,543
Sevelamer Carbonate	Sevelamer Carbonate	66	3,363	$10,586
Calcium Acetate	Calcium Acetate	32	1,384	$2,261
Calcitriol	Calcitriol	127	9,118	$2,192

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	49	$552
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	30	$547
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	29	$479
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	24	$443
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	N	N/R	18	$13

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Mahesh M. Dangal, M.D.?

Tedicare shows public-source Medicare data for Mahesh M. Dangal, M.D. (NPI 1710171129), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mahesh M. Dangal, M.D. have ACO affiliation data?

Mahesh M. Dangal, M.D. is shown with ACO affiliation data for PeaceHealth Direct Contracting LLC (REACH, ACO ID D0152).

What billing organization is linked to Mahesh M. Dangal, M.D.?

Mahesh M. Dangal, M.D. is linked to PEACEHEALTH (billing NPI 1609061969) in the available physician profile data.

Does Mahesh M. Dangal, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.